In a metastatic breast cancer xenograft model harboring constitutive activation of Raf-1, the link between aberrant Raf/MEK/ERK signaling and development of endocrine resistance through abrogation of the ERα signaling axis was elucidated. Here, ESR1 is linked to breast carcinoma.